FDA Inspection 1206141 — Gulf Coast Regional Blood Center at Pearland
The FDA completed an inspection of Gulf Coast Regional Blood Center at Pearland on May 5, 2023 in Pearland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 5, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Pearland, TX (United States)